Article citationsMore >>

Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M. A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics. Clin Rev Allergy Immunol. 2012;42:331-41.

has been cited by the following article:

Article

Anti-tTg-IgA is neither a Solved Problem nor a “closed case” in Celiac Disease Diagnosis

1B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

2AESKU.KIPP Institute, Wendelsheim


International Journal of Celiac Disease. 2017, Vol. 5 No. 3, 97-100
DOI: 10.12691/ijcd-5-3-1
Copyright © 2017 Science and Education Publishing

Cite this paper:
Aaron Lerner, Sandra Neidhöfer, Torsten Matthias. Anti-tTg-IgA is neither a Solved Problem nor a “closed case” in Celiac Disease Diagnosis. International Journal of Celiac Disease. 2017; 5(3):97-100. doi: 10.12691/ijcd-5-3-1.

Correspondence to: Aaron  Lerner, B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Email: aaronlerner1948@gmail.com

Abstract

Anti-tissue transglutaminase (tTg) IgA are considered the most frequently used serological marker for celiac disease diagnosis. Despite its recommended leading position by the 2012 ESPGHAN diagnostic criteria, it exposes multiple false positive and negative titers. In view of the critical opinions expressed lately in the literature against the application of those criteria, the bias in the central place occupied by tTg-IgA in the new ESPGHAN CD Diagnostic Guidelines and the emergence of newer serological marker for celiac disease, it is hoped that the revised guidelines will open up the limited, problematic and single Tg2-IgA antibody for other or additional single or combined serological diagnostic markers.

Keywords